RxDoctor Payments Data

Andrea Wickus, PA

Physician Assistant · Leesport, PANPI 1104881879

Payments from drug & device makers

$1,527in general payments, 2019–2025

Across 103 payments — averaging $14.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$244
  • Novo Nordisk$201
  • GSK$172
  • AstraZeneca$146
  • Lilly USA, LLC$131
  • Pfizer$126
  • plus $508 from 10 others

What the payments were for

  • Food & beverage$1,527100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,527 in reported general payments places this provider in the 80th percentile of 6,643 physician assistant providers in Pennsylvania.

See all physician assistant providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$41,996
Medicare patients
182
Services billed
917

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin45$40,032
OzempicSemaglutide25$35,058
EliquisApixaban19$27,804
JanuviaSitagliptin Phosphate31$27,780
FarxigaDapagliflozin Propanediol15$14,723
JanumetSitagliptin Phos/Metformin Hcl19$11,047
VascepaIcosapent Ethyl15$8,801
ContraveNaltrexone Hcl/Bupropion Hcl12$7,208
Spiriva HandihalerTiotropium Bromide12$6,685
Janumet XrSitagliptin Phos/Metformin Hcl12$5,835
NorvascAmlodipine Besylate13$4,437
SynthroidLevothyroxine Sodium42$2,946
Tirosint-SolLevothyroxine Sodium11$1,776
Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide32$1,316
Bisoprolol Fumarate35$1,311

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia, Janumet, Janumet Xr$70$44,66262 claims
Boehringer IngelheimJardiance$89$40,03245 claims
Novo NordiskOzempic$201$35,05825 claims
PfizerEliquis$126$27,80419 claims
AstraZenecaFarxiga$146$14,72315 claims
AbbVieSynthroid$244$2,94642 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 6,643 physician assistant providers in Pennsylvania.

Other physician assistant in Leesport

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →